Adhesion Barriers Market Report 2024

This Adhesion Barriers market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The adhesion barriers market size has grown strongly in recent years. It will grow from $0.78 billion in 2023 to $0.83 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The historical growth can be attributed to several factors, the rising number of surgical procedures globally, increased awareness of postoperative complications and the necessity for adhesion prevention, growing use of minimally invasive surgical methods, the expansion of healthcare infrastructure in developing markets, a heightened focus on patient safety and minimizing postoperative complications, and greater investment in surgical innovations.

The adhesion barriers market size is expected to see strong growth in the next few years. It will grow to $1.09 billion in 2028 at a compound annual growth rate (CAGR) of 7%. The forecast period growth is driven by the increasing frequency of complex and high-risk surgeries, a preference for minimally invasive and laparoscopic procedures, an aging population requiring more surgical interventions, expanded access to healthcare and surgical facilities in emerging regions, a focus on reducing healthcare costs related to postoperative issues, and stronger regulatory support for advanced adhesion barrier products. Key trends for the forecast period include the development of biodegradable and bioresorbable adhesion barriers, advancements in barrier technologies, personalized adhesion barrier solutions, integration of smart and responsive barriers, 3D-printed barriers, and applications in robotic and minimally invasive surgeries.

The increasing incidence of sports-related injuries is expected to drive the growth of the adhesion barriers market in the future. Sports-related injuries refer to physical damage sustained during athletic activities or exercise. This rise in such injuries can be attributed to factors like greater participation in sports, higher levels of competition, inadequate training, and insufficient recovery periods. Adhesion barriers are used in the treatment of sports injuries to prevent scar tissue from adhering to surrounding tissues, promoting a smoother recovery and rehabilitation process. For example, in July 2024, the Australian Institute of Health and Welfare reported that in 2021-22, sports involving wheels and various types of football resulted in the highest number of injury-related hospitalizations. Cycling accounted for approximately 8,600 cases, followed by Australian rules football (4,300), roller sports (4,100), and wheeled motor sports (3,800). Thus, the growing number of sports-related injuries is fueling the expansion of the adhesion barriers market.

Leading companies in the adhesion barriers market are focusing on developing advanced products, such as absorbable adhesion barriers, to gain a competitive edge. An absorbable adhesion barrier is a temporary material used during surgery that breaks down gradually and is absorbed by the body, preventing tissue adhesion as healing progresses. For example, in February 2022, Gunze Limited, a Japan-based provider of bioabsorbable medical materials, introduced TENALEAF, an absorbable adhesion barrier, in Japan. TENALEAF provides surgeons with a new option for both open and minimally invasive surgeries, offering easy manipulation, moderate adhesive strength for repositioning, and adaptable placement. The company aims to boost its visibility by showcasing the product’s features and advantages to both surgeons and patients.

In February 2023, Advanced Medical Solutions Group plc, a UK-based medical technology company, acquired Connexicon Medical Limited for $7.49 million (€7 million). This acquisition was intended to strengthen Advanced Medical Solutions' range of adhesion barriers, improve their surgical wound care offerings, and promote innovation in preventing post-surgical adhesions. Connexicon Medical Limited is an Ireland-based medical device company.

Major companies operating in the adhesion barriers market are Johnson & Johnson Services Inc., Sanofi S.A., Baxter International Inc., Terumo Corporation, Atrium Medical Corporation, Integra LifeSciences Holdings Corporation, Gunze Industries Co. Ltd., Anika Therapeutics Inc., Allosource, CG Bio Inc., Seikagaku Corporation, Hangzhou Singclean Medical Products Co. Ltd., FzioMed Inc., MAST Biosurgery Inc., Betatech Medical Ltd., PlantTec Medical GmbH, Actamax Surgical Materials LLC, Arc Medical Devices Inc., Luna Solutions LLC, CorMatrix Cardiovascular Inc., Innocoll Biotherapeutics N.A. Inc., Leader Biomedical, BiosCompass Inc.

North America was the largest region in the adhesion barriers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adhesion barriers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the adhesion barriers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Adhesion barriers are medical devices designed to prevent or minimize the formation of scar tissue or adhesions following surgery. Typically placed between tissues or organs, these barriers help reduce postoperative complications and enhance recovery outcomes. By stopping adhesions from forming, they alleviate pain and support better functional recovery after surgery.

Adhesion barriers come in several types natural barriers such as collagen and fibrin, and synthetic ones such as hyaluronic acid, regenerated cellulose, and polyethylene glycol. Natural barriers are derived from substances such as collagen or fibrin and prevent tissues from adhering to each other during and after surgical procedures. These barriers are available in different formulations, including films, gels, and liquids. They are used in various types of surgeries - gynecological, general or abdominal, orthopedic, cardiovascular, neurological, urological, and reconstructive. End users include hospitals, clinics, ambulatory surgical centers, and others.

The adhesion barriers market research report is one of a series of new reports that provides adhesion barriers market statistics, including adhesion barriers industry global market size, regional shares, competitors with a adhesion barriers market share, detailed adhesion barriers market segments, market trends and opportunities, and any further data you may need to thrive in the adhesion barriers industry. This adhesion barriers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adhesion barriers market consists of sales of seprafilm, glycosaminoglycans (GAGs) adhesion barrier, evarrest, coseal, bioGlue, and floseal. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.